Search research articles
Contact Us
Filters
Showing results (11-20 of 60) with videos related to
Page
of 6
Sort By:
Frontiers in Pharmacology
|
February 21, 2020
On-Label or Off-Label? Overcoming Regulatory and Financial Barriers to Bring Repurposed Medicines to Cancer Patients
Ciska Verbaanderd, Ilse Rooman, Lydie Meheus, et al.
Scientific Reports
|
March 13, 2019
Adult human pancreatic acinar cells dedifferentiate into an embryonic progenitor-like state in 3D suspension culture
Jonathan Baldan, Isabelle Houbracken, Ilse Rooman, et al.
Virchows Archiv : an International Journal of Pathology
|
December 3, 2003
Exocrine cell transdifferentiation in dexamethasone-treated rat pancreas
Jessy Lardon, Niki Huyens, Ilse Rooman, et al.
Diagnostic Pathology
|
August 30, 2023
Heterotopia of salivary gland tissue in the pancreas
Sandrina Martens, Katarina Coolens, Catharina Olsen, et al.
The Biochemical Journal
|
October 7, 2008
p/CAF modulates the activity of the transcription factor p48/Ptf1a involved in pancreatic acinar differentiation
Annie Rodolosse, Maria-Luisa Campos, Ilse Rooman, et al.
Current Cancer Drug Targets
|
August 19, 2015
Emerging Drug Target In Pancreatic Cancer: Placing Sirtuin 1 on the Canvas
Marc Giry-Laterriere, Andreia V Pinho, Nils Eling, et al.
Ecancermedicalscience
|
December 1, 2016
Repurposing Drugs in Oncology (ReDO)-Propranolol as an anti-cancer agent
Pan Pantziarka, Gauthier Bouche, Vidula Sukhatme, et al.
Cellular and Molecular Gastroenterology and Hepatology
|
December 7, 2021
On the Origin of Pancreatic Cancer: Molecular Tumor Subtypes in Perspective of Exocrine Cell Plasticity
Elyne Backx, Katarina Coolens, Jan-Lars Van den Bossche, et al.
Gastroenterology
|
June 28, 2011
Lineage tracing evidence for transdifferentiation of acinar to duct cells and plasticity of human pancreas
Isabelle Houbracken, Evelien de Waele, Jessy Lardon, et al.
Journal for Immunotherapy of Cancer
|
November 6, 2020
Nicotinamide combined with gemcitabine is an immunomodulatory therapy that restrains pancreatic cancer in mice
Benson Chellakkan Selvanesan, Kiran Meena, Amanda Beck, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 60) with videos related to
Sort By:
Page
of 6
Frontiers in Pharmacology
|
February 21, 2020
On-Label or Off-Label? Overcoming Regulatory and Financial Barriers to Bring Repurposed Medicines to Cancer Patients
Ciska Verbaanderd, Ilse Rooman, Lydie Meheus, et al.
Scientific Reports
|
March 13, 2019
Adult human pancreatic acinar cells dedifferentiate into an embryonic progenitor-like state in 3D suspension culture
Jonathan Baldan, Isabelle Houbracken, Ilse Rooman, et al.
Virchows Archiv : an International Journal of Pathology
|
December 3, 2003
Exocrine cell transdifferentiation in dexamethasone-treated rat pancreas
Jessy Lardon, Niki Huyens, Ilse Rooman, et al.
Diagnostic Pathology
|
August 30, 2023
Heterotopia of salivary gland tissue in the pancreas
Sandrina Martens, Katarina Coolens, Catharina Olsen, et al.
The Biochemical Journal
|
October 7, 2008
p/CAF modulates the activity of the transcription factor p48/Ptf1a involved in pancreatic acinar differentiation
Annie Rodolosse, Maria-Luisa Campos, Ilse Rooman, et al.
Current Cancer Drug Targets
|
August 19, 2015
Emerging Drug Target In Pancreatic Cancer: Placing Sirtuin 1 on the Canvas
Marc Giry-Laterriere, Andreia V Pinho, Nils Eling, et al.
Ecancermedicalscience
|
December 1, 2016
Repurposing Drugs in Oncology (ReDO)-Propranolol as an anti-cancer agent
Pan Pantziarka, Gauthier Bouche, Vidula Sukhatme, et al.
Cellular and Molecular Gastroenterology and Hepatology
|
December 7, 2021
On the Origin of Pancreatic Cancer: Molecular Tumor Subtypes in Perspective of Exocrine Cell Plasticity
Elyne Backx, Katarina Coolens, Jan-Lars Van den Bossche, et al.
Gastroenterology
|
June 28, 2011
Lineage tracing evidence for transdifferentiation of acinar to duct cells and plasticity of human pancreas
Isabelle Houbracken, Evelien de Waele, Jessy Lardon, et al.
Journal for Immunotherapy of Cancer
|
November 6, 2020
Nicotinamide combined with gemcitabine is an immunomodulatory therapy that restrains pancreatic cancer in mice
Benson Chellakkan Selvanesan, Kiran Meena, Amanda Beck, et al.
Page
of 6